Nov 12, 2019 / 04:10PM GMT
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research Analyst
Good morning. It's Matt Miksic, medical device analyst -- U.S. medical device analyst. I'm glad to welcome and introduce Rob Douglas, COO of ResMed, who will go through a presentation and if there's time permitting, we'll have some Q&A at the end of the presentation. But Rob, thanks very much for joining us.
Robert A. Douglas - ResMed Inc. - President & COO
Thanks, Matt. Okay. Thank you. I'm going to give a quick overview of ResMed and of our strategy and a quick recap of recent performance. At the end, there should be some time for questions. So I'm happy to take questions from the audience, as we go through.
So I just skipped over the safe harbor there. Now in terms of ResMed, who are we? We are the leading connected health care company in the world. And I'll explain a little more how this works. But we have the largest network of connected medical devices in the world. And we are using the data that we generate from that
Resmed Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers